The WHO has vigorously promoted directly observed treatment, short-course (DOTS ) strategy since the 1990s and managed to stop the spread of tuberculosis in communities. However, tuberculosis is still the number one killer among infectious diseases, so the mission for tackling the disease remains challenging. Faced with the severe tuberculosis epidemic, the WHO adopted its End TB Strategy (2016-2035) in 2014. 

This project intends to analyze the historical development of tuberculosis prevention and control in different countries and the research progress in diagnosis and treatment. It also outlines appropriate technology experiences, prevention and control policies by comparing practices in China and developed countries with low-prevalence such as France, Germany and the United States, and carries out a comparative study on the characteristics of tuberculosis response in countries with a high tuberculosis burden. 

This project considers China’s national conditions and the characteristics of a modern tuberculosis epidemic to serve the goal of “Healthy China 2030” and the overall requirements of WHO to end the global tuberculosis epidemic by 2035. It carries out a comparative study of health economic data in tuberculosis prevention and control in China and countries with different prevalence. In addition, the project describes a practical and feasible system that meets national conditions. It aims to eliminate isolation in tuberculosis prevention and treatment, and eliminate the isolation of tuberculosis specialist hospitals from general hospitals as it formulates a complete evidence-based, reasonable and targeted report titled the “Comparative Study on Tuberculosis Prevention and Control Systems in China, France and Other Countries”. 

The project aims to build consensus in the in the field, and submit to national decision-making departments a policy basis for formulating a tuberculosis prevention and control system in line with China’s national conditions, so as to ensure early monitoring of key populations, early detection of patients, early treatment of patients, and early warning of relapse, reducing the burden borne by the country, society and family. Finally, this project makes contributions to China’s completion of the WHO program to end the tuberculosis epidemic by 2035 with guaranteed quality and quantity.